{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:06:10Z","timestamp":1783595170516,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T00:00:00Z","timestamp":1495411200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioDrugs"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s40259-017-0221-x","type":"journal-article","created":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T02:24:39Z","timestamp":1495419879000},"page":"239-249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain"],"prefix":"10.1007","volume":"31","author":[{"name":"Spanish Group for the Study of Glomerular Diseases (GLOSEN)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iara","family":"DaSilva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Draibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Praga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Ballar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"D\u00edaz-Encarnaci\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,22]]},"reference":[{"key":"221_CR1","doi-asserted-by":"crossref","unstructured":"International study of kidney disease in children. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. Pediatr. 1981;98(4):561\u20134.","DOI":"10.1016\/S0022-3476(81)80760-3"},{"key":"221_CR2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, et al. Adult minimal-change disease clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007;2:445\u201353.","journal-title":"Clin J Am Soc Nephrol"},{"key":"221_CR3","doi-asserted-by":"crossref","unstructured":"Ruggenenti P, Ruggiero B, Cravedi P, Vivarelli M, Massella L, Maras\u00e0 M, et al. Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. J Am Soc Nephrol 2014;25(4):850\u201363.","DOI":"10.1681\/ASN.2013030251"},{"key":"221_CR4","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/01.ASN.0000135051.62500.97","volume":"15","author":"MJ Chun","year":"2004","unstructured":"Chun MJ, Korbet SM, Schwartz MM, Lewis EJ. Focal segmental glomerulosclerosis in nephrotic adults presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol. 2004;15:2169\u201377.","journal-title":"J Am Soc Nephrol"},{"key":"221_CR5","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2215\/CJN.05691108","volume":"4","author":"HAC Kyrieleis","year":"2009","unstructured":"Kyrieleis HAC, L\u00f6wik MM, Pronk I, Cruysberg HRM, Kremer JAM, Oyen WJG, et al. Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children. Clin J Am Soc Nephrol. 2009;4:1593\u2013600.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 70","key":"221_CR6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1046\/j.1523-1755.1999.07002.x","volume":"55","author":"JM Bargman","year":"1999","unstructured":"Bargman JM. Management of minimal lesion glomerulonephritis: evidence-based recommendations. Kidney Int. 1999;55(Suppl 70):S3\u201316.","journal-title":"Kidney Int"},{"key":"221_CR7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5414\/CNP60242","volume":"60","author":"MJ Kemper","year":"2003","unstructured":"Kemper MJ, Meyer-Jark T, Lilova M, M\u00fcller-Wiefel DE. Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome. Clin Nephrol. 2003;60:242\u20137.","journal-title":"Clin Nephrol"},{"issue":"6","key":"221_CR8","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1681\/ASN.2015050523","volume":"27","author":"M Colucci","year":"2016","unstructured":"Colucci M, Carsetti R, Cascioli S, Casiraghi F, Perna A, Rav\u00e0 L, Ruggiero B, Emma F, Vivarelli M. B Cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome. J Am Soc Nephrol. 2016;27(6):1811\u201322.","journal-title":"J Am Soc Nephrol"},{"key":"221_CR9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00467-007-0640-x","volume":"23","author":"N Makiko","year":"2008","unstructured":"Makiko N, Koichi K, Nozu K, Matsuoka A, et al. Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol. 2008;23:481\u20135.","journal-title":"Pediatr Nephrol."},{"key":"221_CR10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1681\/ASN.2008070786","volume":"21","author":"D Jayne","year":"2010","unstructured":"Jayne D. Role of rituximab therapy in glomerulonephritis. J Am Soc Nephrol. 2010;21:14\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"221_CR11","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","volume":"384","author":"K Iijima","year":"2014","unstructured":"Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, et al. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2014;384:1273\u201381.","journal-title":"Lancet"},{"key":"221_CR12","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00467-006-0228-x","volume":"21","author":"RD Gilbert","year":"2006","unstructured":"Gilbert RD, Hulse E, Rigden S. Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediatr Nephrol. 2006;21:1698\u2013700.","journal-title":"Pediatr Nephrol"},{"key":"221_CR13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00467-012-2319-1","volume":"28","author":"S Ito","year":"2013","unstructured":"Ito S, Kamei K, Ogura M, Udagawa T, Fujinaga S, Saito M, et al. Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome. Pediatr Nephrol. 2013;28:257\u201364.","journal-title":"Pediatr Nephrol"},{"key":"221_CR14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00467-012-2406-3","volume":"28","author":"S Tellier","year":"2013","unstructured":"Tellier S, Brochard K, Garnier A, Bandin F, Llanas B, Guigonis V, et al. Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome. Pediatr Nephrol. 2013;28:911\u20138.","journal-title":"Pediatr Nephrol"},{"key":"221_CR15","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ki.2013.211","volume":"84","author":"P Ravani","year":"2013","unstructured":"Ravani P, Ponticelli A, Siciliano C, Fornoni A, Magnasco A, Sica F, et al. Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Kidney Int. 2013;84:1025\u201333.","journal-title":"Kidney Int"},{"key":"221_CR16","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2215\/CJN.03470410","volume":"5","author":"A Gulati","year":"2010","unstructured":"Gulati A, Sinha A, Jordan SC, Hari P, Dinda AK, Sharma S, et al. Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome multicentric report. Clin J Am Soc Nephrol. 2010;5:2207\u201312.","journal-title":"Clin J Am Soc Nephrol"},{"key":"221_CR17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.ajkd.2006.10.015","volume":"49","author":"H Fran\u00e7ois","year":"2007","unstructured":"Fran\u00e7ois H, Daugas E, Bensman A, Ronco P. Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult first case report and pathophysiological considerations. Am J Kidney Dis. 2007;49:158\u201361.","journal-title":"Am J Kidney Dis"},{"issue":"29","key":"221_CR18","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1097\/MD.0000000000000300","volume":"93","author":"Y Iwabuchi","year":"2014","unstructured":"Iwabuchi Y, Takei T, Moriyama T, Itabashi M, Nitta K. Long-term prognosis of adult patients with steroid-dependent minimal change nephrotic syndrome following rituximab treatment. Medicine (Baltimore). 2014;93(29):e300.","journal-title":"Medicine (Baltimore)"},{"key":"221_CR19","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/ndt\/gft312","volume":"29","author":"A Bruchfeld","year":"2014","unstructured":"Bruchfeld A, Benedek S, Hilderman M, Medin C, Snaedal-Jonsdottir S, Korkeila M. Rituximab for minimal change disease in adults Long-term follow-up. Nephrol Dial Transpl. 2014;29:851\u20136.","journal-title":"Nephrol Dial Transpl"},{"key":"221_CR20","first-page":"1","volume":"2084","author":"J Guitard","year":"2014","unstructured":"Guitard J, Hebral A-L, Fakhouri F, Joly D, Daugas E, Rivalan J, et al. Rituximab for minimal-change nephrotic syndrome in adulthood predictive factors for response, long-term outcomes and tolerance. Nephrol Dial Transpl. 2014;2084:1\u20138.","journal-title":"Nephrol Dial Transpl"},{"key":"221_CR21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ki.2012.444","volume":"83","author":"H Munyentwali","year":"2013","unstructured":"Munyentwali H, Bouachi K, Audard V, Remy P, Lang P, Mojaat R, et al. Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease. Kidney Int. 2013;83:511\u20136.","journal-title":"Kidney Int"},{"issue":"4","key":"221_CR22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000360908","volume":"39","author":"Kronbichler Al","year":"2014","unstructured":"Al Kronbichler. Kerschbaum J, Fernandez-Fresnedo G, Hoxha E, Kurschat CE, Busch M, Bruchfeld A, Mayer G, Rudnicki M. Rituximab treatment for relapsing minimal change disease and focal segmental glomerulosclerosis a systematic review. Am J Nephrol. 2014;39(4):322\u201330.","journal-title":"Am J Nephrol."},{"key":"221_CR23","doi-asserted-by":"crossref","unstructured":"KDIGO Guidelines. Chapter 6 Idiopathic focal segmental glomerulosclerosis in adults. Kidney Int Suppl 2012;2(2):181\u2013185.","DOI":"10.1038\/kisup.2012.19"},{"key":"221_CR24","doi-asserted-by":"crossref","unstructured":"KDIGO Guidelines. Chapter 3 Steroid-sensitive nephrotic syndrome in children. Kidney Int Suppl 2012;2(2):163\u2013171.","DOI":"10.1038\/kisup.2012.16"},{"key":"221_CR25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","volume":"53","author":"AS Levey","year":"2007","unstructured":"Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766\u201372.","journal-title":"Clin Chem"},{"key":"221_CR26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00467-006-0427-5","volume":"22","author":"GC Smith","year":"2007","unstructured":"Smith GC. Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome? Pediatr Nephrol. 2007;22:893\u20138.","journal-title":"Pediatr Nephrol"},{"key":"221_CR27","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00467-009-1191-0","volume":"24","author":"K Kamei","year":"2009","unstructured":"Kamei K, Ito S, Nozu K, Fujinaga S, Nakayama M, Sako M, et al. Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Pediatr Nephrol. 2009;24:1321\u20138.","journal-title":"Pediatr Nephrol"},{"key":"221_CR28","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/ndt\/gfs515","volume":"28","author":"T Takei","year":"2013","unstructured":"Takei T, Itabashi M, Moriyama T, Kojima C, Shiohira S, Shimizu A, et al. Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults. Nephrol Dial Transplant. 2013;28:1225\u201332.","journal-title":"Nephrol Dial Transplant"},{"key":"221_CR29","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/ndt\/gfr548","volume":"27","author":"MJ Kemper","year":"2012","unstructured":"Kemper MJ, Gellermann J, Habbig S, Krmar RT, Dittrich K, Jungraithmayr T, et al. Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome. Nephrol Dial Transplant. 2012;27:1910\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"221_CR30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00467-007-0640-x","volume":"23","author":"M Nakayama","year":"2008","unstructured":"Nakayama M, Kamei K, Nozu K, Matsuoka K, Nakagawa A, Sako M, et al. Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol. 2008;23:481\u20135.","journal-title":"Pediatr Nephrol"},{"issue":"3\u20134","key":"221_CR31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000368590","volume":"128","author":"A Kronbichler","year":"2014","unstructured":"Kronbichler A, Bruchfeld A. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis. Nephron Clin Pract. 2014;128(3\u20134):277\u201382.","journal-title":"Nephron Clin Pract"},{"key":"221_CR32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrneph.2012.289","volume":"9","author":"A Sinha","year":"2013","unstructured":"Sinha A, Bagga A. Rituximab therapy in nephrotic syndrome implications for patients\u2019 management. Nat Rev Nephrol. 2013;9:154\u201369.","journal-title":"Nat Rev Nephrol"},{"key":"221_CR33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00467-012-2314-6","volume":"28","author":"J Kumar","year":"2013","unstructured":"Kumar J, Shatat IF, Skversky AL, Woroniecki RP, Del Rio M, Perelstein EM, et al. Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis. Pediatr Nephrol. 2013;28:333\u20138.","journal-title":"Pediatr Nephrol"},{"key":"221_CR34","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ndt\/gfr405","volume":"27","author":"A-L Sellier-Leclerc","year":"2012","unstructured":"Sellier-Leclerc A-L, Baudouin V, Kwon T, Macher M-A, Gu\u00e9rin V, Lapillonne H, et al. Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood\u2013follow-up after CD19 recovery. Nephrol Dial Transplant. 2012;27:1083\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"221_CR35","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","volume":"23","author":"V Guigonis","year":"2008","unstructured":"Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, et al. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome a multicentric series of 22 cases. Pediatr Nephrol. 2008;23:1269\u201379.","journal-title":"Pediatr Nephrol"},{"key":"221_CR36","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.2215\/CJN.05080610","volume":"5","author":"FC Fervenza","year":"2010","unstructured":"Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, et al. Rituximab therapy in idiopathic membranous nephropathy a 2-year study. Clin J Am Soc Nephrol. 2010;5:2188\u201398.","journal-title":"Clin J Am Soc Nephrol"},{"key":"221_CR37","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","volume":"3","author":"A Fornoni","year":"2011","unstructured":"Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, et al. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med. 2011;3:85ra46.","journal-title":"Sci Transl Med"},{"key":"221_CR38","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00467-011-1778-0","volume":"26","author":"JA Kari","year":"2011","unstructured":"Kari JA, El-Morshedy SM, El-Desoky S, Alshaya HO, Rahim KA, Edrees BM. Rituximab for refractory cases of childhood nephrotic syndrome. Pediatr Nephrol. 2011;26:733\u20137.","journal-title":"Pediatr Nephrol"},{"key":"221_CR39","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","volume":"6","author":"P Ravani","year":"2011","unstructured":"Ravani P, Magnasco A, Edefonti A, Murer L, Rossi R, Ghio L, et al. Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome a randomized controlled trial. Clin J Am Soc Nephrol. 2011;6:1308\u201315.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["BioDrugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40259-017-0221-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-017-0221-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-017-0221-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T02:28:45Z","timestamp":1495592925000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40259-017-0221-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,22]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["221"],"URL":"https:\/\/doi.org\/10.1007\/s40259-017-0221-x","relation":{},"ISSN":["1173-8804","1179-190X"],"issn-type":[{"value":"1173-8804","type":"print"},{"value":"1179-190X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,22]]}}}